InVivo Therapeutics

During the summer, InVivo completed a primate and rodent study that demonstrated InVivo’s polymer-based technologies to be 100 percent effective, said Frank Reynolds,CEO of the Cambridge-based company.
Read More

Frank Reynolds, the CEO of Cambridge, MA-based InVivo Therapeutics, says he still feels pain in his lower back when he steps off a curb. The pain stems from the spinal cord injury Reynolds suffered in an auto accident in 1992. It’s no coincidence that today he is running a medical technology firm with an implant that could prevent some cases of paralysis.
Read More

InVivo Therapeutics Corporation announced today that Nobel-prize winning scientist Richard Roberts, PhD, will join its Board of Directors and that renowned spinal cord expert V. Reggie Edgerton, PhD, of the University of California, Los Angeles (UCLA) has joined the company’s scientific advisory board (SAB).
Read More

Langer is currently a Professor at the Massachusetts Institute of Technology (MIT), where he directs one of the most internationally renowned biomedical research laboratory in the world. Although he received his bachelor´s degree in Chemical Engineering, he carried out postdoctoral research in Medicine, which marked the course of his future research, situated on the interface between Materials Science and Biotechnology.
Read More

InVivo Therapeutics Corporation has appointed Eric Woodard, MD, as Chief Medical Officer and Robin Newman, RN, RAC as Director of Clinical and Regulatory Affairs, the company announced today.
Read More

Dr. Richard Roberts honored by the monarch honored for his services to molecular biology and UK science.
Read More

Dr. Langer speaks about winning the 2008 Millennium Prize
Watch Video